E
Elicera Therapeutics AB
F:8E8
Elicera Therapeutics AB
F:8E8
Price:
0.468
EUR
0.32%
Market Cap:
€16.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
DraftKings Inc
NASDAQ:DKNG
|
US |
|
J
|
JCDecaux SA
XBER:DCS
|
FR |
|
S
|
Selective Insurance Group Inc
F:SV2
|
US |
|
ContraFect Corp
OTC:CFRXQ
|
US |
|
P
|
Prime Energy PE Ltd
TASE:PRIM
|
IL |
|
T
|
Tellhow Sci-Tech Co Ltd
SSE:600590
|
CN |
|
GNCC Capital Inc
OTC:GNCP
|
US |
|
Shunfeng International Clean Energy Ltd
HKEX:1165
|
CN |
|
CN Logistics International Holdings Ltd
HKEX:2130
|
HK |
|
C
|
ClouDr Group Ltd
HKEX:9955
|
CN |
|
O
|
OVB Holding AG
DUS:O4B
|
DE |
|
G
|
Genes Tech Group Holdings Co Ltd
HKEX:8257
|
TW |
|
Green Chemical Co Ltd
KRX:083420
|
KR |
|
A
|
Aebi Schmidt Holding AG
NASDAQ:AEBI
|
CH |
|
Sky Energy Indonesia Tbk PT
IDX:JSKY
|
ID |
|
B
|
BGMC International Ltd
HKEX:1693
|
MY |
|
Yamaya Corp
TSE:9994
|
JP |
|
B
|
Bloomios Inc
OTC:BLMS
|
US |
|
Jiangsu Hagong Intelligent Robot Co Ltd
SZSE:000584
|
CN |
|
D
|
Dongkuk Industries Co Ltd
KOSDAQ:005160
|
KR |
|
C
|
Chi Ho Development Holdings Ltd
HKEX:8423
|
HK |
|
A
|
Adamant Holding Inc
CNSX:ADMT
|
CA |
Balance Sheet
Balance Sheet Decomposition
Elicera Therapeutics AB
Elicera Therapeutics AB
Balance Sheet Decomposition is not available for
Elicera Therapeutics AB
Elicera Therapeutics AB
Balance Sheet
Elicera Therapeutics AB
Elicera Therapeutics AB
Currency: SEK
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
12
|
52
|
44
|
29
|
26
|
25
|
|
| Cash |
12
|
52
|
44
|
29
|
26
|
25
|
|
| Total Receivables |
0
|
0
|
2
|
1
|
1
|
3
|
|
| Other Current Assets |
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
54
|
46
|
30
|
28
|
27
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
13
N/A
|
55
+335%
|
46
-15%
|
30
-35%
|
28
-9%
|
27
-1%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
2
|
1
|
1
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
13
|
12
|
4
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
14
|
14
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+6%
|
14
+440%
|
14
+2%
|
7
-51%
|
4
-40%
|
|
| Equity | |||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
2
|
|
| Retained Earnings |
2
|
15
|
35
|
51
|
67
|
85
|
|
| Additional Paid In Capital |
12
|
67
|
67
|
62
|
87
|
106
|
|
| Other Equity |
0
|
0
|
0
|
5
|
0
|
0
|
|
| Total Equity |
10
N/A
|
52
+410%
|
33
-37%
|
16
-50%
|
21
+27%
|
23
+12%
|
|
| Total Liabilities & Equity |
13
N/A
|
55
+335%
|
46
-15%
|
30
-35%
|
28
-9%
|
27
-1%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
20
|
20
|
20
|
20
|
35
|
49
|
|
Switch to:
Switch to:
See Also
Discover More
